019163967

YELLOWSTONE BIOSCIENCES

---

March 26, 2025

Trademark Summary

The trademark application YELLOWSTONE BIOSCIENCES was filed by Yellowstone Biosciences Limited, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). Application filed.

The application was filed in English (French was selected as the second language).

---

Goods And Services

• The mark was filed in class 5 with following description of goods:
  
  1. Pharmaceutical preparations and substances
  2. Immunotherapy preparations
  3. Pharmaceutical and biological preparations and substances for immunotherapy
  4. Therapeutic vaccines
  5. Genetic medicines
  6. Soluble T-cell receptor (TCT) based therapies
  7. Diagnostic reagents for medical purposes
  8. Synthetic peptides, proteins and cells for pharmaceutical purposes
  9. Peptides, proteins and cells for medical, diagnostic or therapeutic purposes
  10. In vitro diagnostic reagents, in vivo diagnostic reagents, immunological reagents for medical use
  11. Biological reagents for medical/clinical diagnosis
  12. Diagnostic kits comprising reagents and medical diagnostic tests
  13. Biological reagents for medical research
  14. Biological reagents for medical use
  15. Biological preparations for medical use
  16. Immuno-therapeutic agents
  17. Antigen binding molecules, antibodies, antibody fragments, bi-specific T cell engagers (BiTEs), T cell receptors (TCRs) and chimeric antigen receptors (CARs)
  18. Pharmaceutical preparations and substances for the treatment of cancer
  19. Biotechnological preparations for the treatment of cancer
  20. Immunotherapy preparations for the treatment of cancer
  21. Genetic medicines for the treatment of cancer
  22. Soluble T-cell receptor (TCR) based therapies for the treatment of cancer
  23. Immunotherapy products in oncology
  24. Preparation of therapeutic vaccines in oncology for human use
  25. Preparation of immunotherapy products in oncology for human use
  26. T-cell receptors
  27. Immunotherapy preparations comprising engineered T-cell receptors
  28. Immunotherapy preparations comprising genes encoding engineered T-cell receptors
  29. All of the aforesaid goods only for use in connection with immunotherapy.
• The mark was filed in class 42 with following description of goods:
  
  1. Scientific, medical and pharmaceutical research and development services in the field of immunotherapy
  2. Pharmaceutical drug development services
  3. Research and development of pharmaceutical preparations
  4. Research and analysis services
  5. Biological research
  6. Clinical research
  7. Scientific research in the field of chemistry, biochemistry and biology
  8. Services of a biological, biochemical or chemical laboratory
  9. Performing of biological, biochemical or chemical analysis
  10. Cancer diagnostics for scientific purposes
  11. Biological and biochemical examination services
  12. Tests in laboratories
  13. Development of testing methods
  14. Research, development, technical design, testing, design and development of software in the field of biology
  15. Consultancy and analysis services in the field of immuno-therapeutics and in particular immune-oncology
  16. Pharmaceutical product research and development
  17. Biotechnology research and development
  18. Vaccine and immunotherapy research and development
  19. Research and development services in relation to pharmaceutical preparations and substances
  20. Research and development services in relation to pharmaceutical and biological preparations and substances for immunotherapy
  21. Research and development services in relation to gene therapy, cell therapy and genetic medicines
  22. Pharmaceutical and biological research and development services in connection with the treatment of cancer
  23. Research and development services in connection with gene therapy, cell therapy, genetic medicines and soluble T-cell receptor (TCR) based therapies for the treatment of cancer
  24. Advice, information and consultancy in connection with all of the aforesaid services
  25. All of the aforesaid services only for use in connection with immunotherapy.
• The mark was filed in class 44 with following description of goods:
  
  1. Provision of medical information
  2. Provision of medical information via a website
  3. Medical counselling and medical information relating to pharmaceuticals, immunotherapy, immune-therapeutic treatments, therapeutic vaccines and genetic medicines
  4. Services of a medical laboratory, providing medical supply for therapy, in particular supply of peptides, proteins or cells for immuno-therapy
  5. Medical diagnostics
  6. Medical monitoring, testing, inspection and analysis services relating to the diagnosis and treatment by immune-therapeutics
  7. Medical and pharmaceutical consultancy
  8. Provision of medical information and services in the field of immuno-therapeutics
  9. Provision of medical treatment services and medical information services in relation to immuno-therapeutics.